[Form 4] Option Care Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Option Care Health director Harry M. Kraemer Jr. purchased 36,000 shares of common stock on 08/20/2025 at a weighted average price of $27.1466 per share, increasing his direct beneficial ownership to 375,390 shares. The Form 4 reports the purchases were executed in multiple transactions with individual prices ranging from $26.92 to $27.20 per share, and notes the reporting person will provide detailed allocation information upon request. The filing identifies Mr. Kraemer as a director and indicates the transaction code as "P" for purchase.

Positive

• Director purchase of 36,000 shares indicates insider buying activity
• Direct beneficial ownership increased to 375,390 shares, showing added insider stake
• Purchase prices disclosed with weighted average $27.1466 and range $26.92–$27.20

Negative

• None.

Insights

Financial Analyst

TL;DR: Director purchases 36,000 OPCH shares at ~$27.15, modestly increasing direct ownership; transaction is informative but not materially transformative.

The director acquisition of 36,000 shares at a weighted average price of $27.1466 increases direct holdings to 375,390 shares. This is a routine insider purchase reported on Form 4 with purchase prices ranging $26.92–$27.20. For investors, the trade signals insider acquisition but does not meet typical materiality thresholds that would suggest a major shift in control or capital structure. The filing’s disclosure that individual price allocations are available on request is standard for bundled transactions executed across multiple fills.

Corporate Governance Expert

TL;DR: A director-level purchase recorded on Form 4 shows alignment with share ownership but appears routine and non-disruptive to governance.

Harry M. Kraemer Jr. is identified as a director and the Form 4 reports direct beneficial ownership after the purchase. The transaction code "P" and the explanation about multiple transaction prices follow standard disclosure practice. There are no disclosures of derivative transactions, sales, or changes to officer roles. From a governance perspective, this is a normal insider buy with no indicated change to board composition or executive responsibilities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRAEMER HARRY M JANSEN JR

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		P		36,000	A	$27.1466(1)	375,390	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average price of 36,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $26.92 to $27.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

	/s/ Michael Shapiro, attorney-in-fact for Mr. Kraemer	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OPCH director Harry M. Kraemer Jr. report on Form 4?

He reported purchasing 36,000 shares of Option Care Health common stock on 08/20/2025, increasing his direct ownership to 375,390 shares.

At what price were the OPCH shares purchased according to the Form 4?

The Form 4 reports a weighted average purchase price of $27.1466 per share, with individual purchase prices ranging from $26.92 to $27.20.

Does the filing indicate the purchases were single or multiple transactions?

The filing states the 36,000 shares were purchased in multiple transactions on the reported transaction date and that allocation details are available upon request.

What is the reporting person's relationship to OPCH?

The Form 4 identifies the reporting person, Harry M. Kraemer Jr., as a director of Option Care Health, Inc.

Are any derivative transactions reported for the reporting person?

No derivative securities transactions are reported in Table II of the Form 4; only the non-derivative common stock purchases are disclosed.